By slicing and dicing the data, the study confirms MITRA-FR as an outlier and emphasizes the need for careful patient selection.
Find out more about favourable imaging techniques in mortality rates and early detection among survivors of breast cancer.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results